High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment

被引:58
|
作者
Di Veroli, Giovanni Y. [1 ]
Davies, Mark R.
Zhang, Henggui
Abi-Gerges, Najah
Boyett, Mark R. [1 ]
机构
[1] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9NT, Lancs, England
关键词
computational modeling; human ether-a-go-go-related gene ion channel; drug-binding kinetics; QT prolongation; Torsades de Pointes arrhythmia; QT INTERVAL PROLONGATION; POTASSIUM CHANNEL; I-KR; VENTRICULAR ARRHYTHMIA; PROARRHYTHMIC RISK; ION CHANNELS; REPOLARIZATION; ELECTROPHYSIOLOGY; CISAPRIDE; BLOCK;
D O I
10.1152/ajpheart.00511.2012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Di Veroli GY, Davies MR, Zhang H, Abi-Gerges N, Boyett MR. High-throughput screening of drug-binding dynamics to HERG improves early drug safety assessment. Am J Physiol Heart Circ Physiol 304: H104-H117, 2013. First published October 26, 2012; doi:10.1152/ajpheart.00511.2012.-The use of computational models to predict drug-induced changes in the action potential (AP) is a promising approach to reduce drug safety attrition but requires a better representation of more complex drug-target interactions to improve the quantitative prediction. The blockade of the human ether-a-go-go-related gene (HERG) channel is a major concern for QT prolongation and Torsade de Pointes risk. We aim to develop quantitative in-silico AP predictions based on a new electrophysiological protocol (suitable for high-throughput HERG screening) and mathematical modeling of ionic currents. Electrophysiological recordings using the IonWorks device were made from HERG channels stably expressed in Chinese hamster ovary cells. A new protocol that delineates inhibition over time was applied to assess dofetilide, cisapride, and almokalant effects. Dynamic effects displayed distinct profiles for these drugs compared with concentration-effects curves. Binding kinetics to specific states were identified using a new HERG Markov model. The model was then modified to represent the canine rapid delayed rectifier K+ current at 37 degrees C and carry out AP predictions. Predictions were compared with a simpler model based on conductance reduction and were found to be much closer to experimental data. Improved sensitivity to concentration and pacing frequency variables was obtained when including binding kinetics. Our new electrophysiological protocol is suitable for high-throughput screening and is able to distinguish drug-binding kinetics. The association of this protocol with our modeling approach indicates that quantitative predictions of AP modulation can be obtained, which is a significant improvement compared with traditional conductance reduction methods.
引用
收藏
页码:H104 / H117
页数:14
相关论文
共 50 条
  • [41] High-throughput drug screening instruments grow increasingly sophisticated
    Dutton, G
    GENETIC ENGINEERING NEWS, 1997, 17 (09): : 8 - &
  • [42] Establishment and validation of pheochromocytoma organoids for high-throughput drug screening
    Calucho, Maite
    Cheng, ZiMing
    Nguyen, Huyen Thi-Lam
    Al Shihabi, Ahmad
    Gonzalez-Cantu, Hector
    Guo, Qianjin
    Thaker, Maneesha
    Bechmann, Nicole
    Eisenhofer, Graeme
    Ding, Yanli
    Dahia, Patricia
    Soragni, Alice
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Beckman and Sagian integrate systems for high-throughput drug screening
    Schneider, I
    GENETIC ENGINEERING NEWS, 1996, 16 (10): : 10 - +
  • [44] High-throughput screening of biocatalytic activity: applications in drug discovery
    Kumar, RA
    Clark, DS
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2006, 10 (02) : 162 - 168
  • [45] High-throughput screening: The ultimate goal of preclinical drug metabolism
    Rodrigues, AD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1231 - U1231
  • [46] Computational High-throughput Screening of Drug-Membrane Thermodynamics
    Bereau, Tristan
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 557A - 557A
  • [47] High-Throughput Screening and Drug Development to Fix RyR Pathology
    Rebbeck, Robyn T.
    Rozman, Kaja
    Evans, Gabrielle M.
    Schwarz, Jacob
    Baran, Marzena
    Aldrich, Courtney C.
    Bers, Donald M.
    Thomas, David D.
    Cornea, Razvan L.
    BIOPHYSICAL JOURNAL, 2021, 120 (03) : 148A - 149A
  • [48] Engineering a Brain Cancer Chip for High-throughput Drug Screening
    Yantao Fan
    Duong Thanh Nguyen
    Yasemin Akay
    Feng Xu
    Metin Akay
    Scientific Reports, 6
  • [49] High-throughput screening approaches for investigating drug metabolism and pharmacokinetics
    Roberts, SA
    XENOBIOTICA, 2001, 31 (8-9) : 557 - 589
  • [50] Recent patent applications in high-throughput drug screening.
    不详
    Nature Biotechnology, 2010, 28 (4) : 329 - 329